A hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic programmed alteration in offspring rats of IUGR induced by prenatal caffeine ingestion

Toxicology and Applied Pharmacology

Volumn 264, Issue 3, 2012, Pages 395-403

  Xu, D ^a,b   Wu, Y ^a   Liu, F ^a   Liu, Y S ^a   Shen, L ^a   Lei, Y Y ^a   Liu, J ^a   Ping, J ^a,b   Qin, J ^c   Zhang, C ^a   Chen, L B ^c   Magdalou, J ^d   Wang, H ^a,b  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d Biopôle de l Université de Lorraine   (France)

Author keywords

Caffeine; Glucocorticoid; Glucose and lipid metabolism; Hypothalamic pituitary adrenal axis; Intrauterine growth retardation

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CAFFEINE; CHOLESTEROL; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; GLUCOSE; MINERALOCORTICOID RECEPTOR; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; FEMALE; FETUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAUTERINE GROWTH RETARDATION; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; NONHUMAN; PRENATAL EXPOSURE; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BIRTH WEIGHT; BLOOD GLUCOSE; CAFFEINE; FEMALE; FETAL GROWTH RETARDATION; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIPID METABOLISM; MALE; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; STRESS, PHYSIOLOGICAL; TIME FACTORS; WEIGHT GAIN;

RATTUS;

EID: 84867885139     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.08.016     Document Type: Article

References (46)

1. Alisi A., Panera N., Agostoni C., Nobili V. Intrauterine growth retardation and nonalcoholic fatty liver disease in children. Int. J. Endocrinol. 2011, 2011:269853.
2. Anagnostis P., Athyros V.G., Tziomalos K., Karagiannis A., Mikhailidis D.P. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 2009, 94:2692-2701.
3. Barker D.J., Hales C.N., Fall C.H., Osmond C., Phipps K., Clark P.M. Type 2 (non-insulin-dependent) diabetes mellitus, hyper tension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-67.
4. Barone J.J., Roberts H.R. Caffeine consumption. Food Chem. Toxicol. 1996, 34:119-129.
5. Brabant G., Muller G., Horn R., Anderwald C., Roden M., Nave H. Hepatic leptin signaling in obesity. FASEB J. 2005, 19:1048-1050.
6. Brent R.L., Christian M.S., Diener R.M. Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res. B Dev. Reprod. Toxicol. 2011, 92:152-187.
7. Cayetanot F., Larnicol N., Peyronnet J. Antenatal environmental stress and maturation of the breathing control, experimental data. Respir. Physiol. Neurobiol. 2009, 168:92-100.
8. Chang L., Chiang S.H., Saltiel A.R. Insulin signaling and the regulation of glucose transport. Mol. Med. 2004, 10:65-71.
9. Christian M.S., Brent R.L. Teratogen update: evaluation of the reproductive and developmental risks of caffeine. Teratology 2001, 64:51-78.
10. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19:269-301.
11. de Quervain D.J., Aerni A., Schelling G., Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Front. Neuroendocrinol. 2009, 30:358-370.
12. Delaunay F., Khan A., Cintra A., Davani B., Ling Z.C., Andersson A., Ostenson C.G., Gustafsson J., Efendic S., Okret S. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J. Clin. Invest. 1997, 100:2094-2098.
13. Desai M., Gayle D., Babu J., Ross M.G. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R91-R96.
14. Ford E.S., Li C., Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J. Diabetes 2010, 2:180-193.
15. Fowden A.L., Giussani D.A., Forhead A.J. Endocrine and metabolic programming during intrauterine development. Early Hum. Dev. 2005, 81:723-734.
16. Fowden A.L., Forhead A.J., Coan P.M., Burton G.J. J. Neuroendocrinol. 2008, 20:439-450.
17. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., Whelton P.K., He J. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005, 365:1398-1405. InterASIA Collaborative Group.
18. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133.
19. Huang L.Z., Liu X., Griffith W.H., Winzer-Serhan U.H. Chronic neonatal nicotine increases anxiety but does not impair cognition in adult rats. Behav. Neurosci. 2007, 121:1342-1352.
20. Huang J., Zhou S., Ping J., Pan X.L., Liang G., Xu D., Hou H., Bao C., Wang H. Role of p53-dependent placental apoptosis in the reproductive and developmental toxicities of caffeine in rodents. Clin. Exp. Pharmacol. Physiol. 2012, 39:357-363.
21. James J., Thomas P., Cavan D., Kerr D. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. BMJ 2004, 328:1237.
22. Kanaka-Gantenbein C. Fetal origins of adult diabetes. Ann. N. Y. Acad. Sci. 2010, 1205:99-105.
23. Kim C.K., Giberson P.K., Yu W., Zoeller R.T., Weinberg J. Effects of prenatal ethanol exposure on hypothalamic-pituitary-adrenal responses to chronic cold stress in rats. Alcohol. Clin. Exp. Res. 1999, 23:301-310.
24. Lingas R.I., Matthews S.G. A short period of maternal nutrient restriction in late gestation modifies pituitary-adrenal function in adult guinea pig offspring. Neuroendocrinology 2001, 73:302-311.
25. Liu Y.S., Xu D., Feng J.H., Kou H., Liang G., Yu H., He X.H., Zhang B.F., Chen L.B., Magdaloue J., Wang H. Fetal rat metabonome alteration by prenatal caffeine ingestion probably due to the increased circulatory glucocorticoid level and altered peripheral glucose and lipid metabolic pathways. Toxicol. Appl. Pharmacol. 2012, 262:205-216.
26. Lopez-Bermejo A., Botas P., Funahashi T., Delgado E., Kihara S., Ricart W., Fernandez-Real J.M. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin. Endocrinol. (Oxf) 2004, 60:256-263.
27. McCormick C.M., Smythe J.W., Sharma S., Meaney M.J. Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Brain Res. Dev. Brain Res. 1995, 84:55-61.
28. McNeil C.J., Nwagwu M.O., Finch A.M., Page K.R., Thain A., McArdle H.J., Ashworth C.J. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth. Reproduction 2007, 133:653-661.
29. Momoi N., Tinney J.P., Liu L.J., Elshershari H., Hoffmann P.J., Ralphe J.C., Keller B.B., Tobita K. Modest maternal caffeine exposure affects developing embryonic cardiovascular function and growth. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2248-H2256.
30. Radosavljevic T., Todorovic V., Vucevic D., Sikic B. The growth hormone axis and insulin-like growth factors. Med. Pregl. 2005, 58:558-562.
31. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22:659-661.
32. Reynolds R.M. Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes. J. Steroid Biochem. Mol. Biol. 2010, 122:3-9.
33. Schaefer T.L., Skelton M.R., Herring N.R., Gudelsky G.A., Vorhees C.V., Williams M.T. Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. J. Neurochem. 2008, 104:1674-1685.
34. Seckl J.R. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?. Front. Neuroendocrinol. 1997, 18:49-99.
35. Silveira V.M., Horta B.L. Birth weight and metabolic syndrome in adults: meta-analysis. Rev. Saude Publica 2008, 42:10-18.
36. Thamotharan M., Shin B.C., Suddirikku D.T., Thamotharan S., Garg M., Devaskar S.U. GLUT4 expression and subcellular localization in the intrauterine growth-restricted adult rat female offspring. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E935-E947.
37. Thayer P.S., Palm P.E. A current assessment of the mutagenic and teratogenic effects of caffeine. CRC Crit. Rev. Toxicol. 1975, 3:345-369.
38. Van de Kar L.D., Richardson-Morton K.D., Rittenhouse P.A. Stress: neuroendocrine and pharmacological mechanisms. Methods Achiev. Exp. Pathol. 1991, 14:133-173.
39. Vieau D., Sebaai N., Leonhardt M., Dutriez-Casteloot I., Molendi-Coste O., Laborie C., Breton C., Deloof S., Lesage J. HPA axis programming by maternal undernutrition in the male rat offspring. Psychoneuroendocrinology 2007, 32:S16-S20.
40. Wan S.L., Liao M.Y., Hao R.S., Li Z.F., Sun G. Colocalization of 11β-hydroxysteroid dehydrogenase type I and glucocorticoid receptor and its significance in rat hippocampus. Acta Physiol. Sin. 2002, 54:473-478.
41. Welberg L.A., Seckl J.R., Holmes M.C. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 2001, 104:71-79.
42. Xita N., Tsatsoulis A. Fetal origins of the metabolic syndrome. Ann. N. Y. Acad. Sci. 2010, 1205:148-155.
43. Xu D., Zhang B.J., Liang G., Ping J., Kou H., Li X.J., Xiong J., Chen L.B., Magdalou J., Wang H. Caffeine-induced activated glucocorticoid metabolism in the hippocampus causes hypothalamic-pituitary-adrenal axis inhibition in fetal rats. PLOS ONE PONE-D-11-23816R3 2012, 10.1371/journal.pone.0044497.
44. Yang Z., Guo C., Zhu P., Li W., Myatt L., Sun K. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts. J. Endocrinol. 2007, 195:241-253.
45. Zhe D., Fang H., Yuxiu S. Expressions of hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the single-prolonged stress-rats. Acta Histochem. Cytochem. 2008, 41:89-95.
46. Zhuang Y.L. Morden Obstetrics 2003, Science press, Beijing. first ed.